Literature DB >> 24315728

Age and duration of inflammatory environment differentially affect the neuroimmune response and catecholaminergic neurons in the midbrain and brainstem.

Isabelle Bardou1, Roxanne M Kaercher1, Holly M Brothers1, Sarah C Hopp1, Sarah Royer1, Gary L Wenk2.   

Abstract

Neuroinflammation and degeneration of ascending catecholaminergic systems occur early in the neurodegenerative process. Age and the duration of a pro-inflammatory environment induced by continuous intraventricular lipopolysaccharide (LPS) differentially affect the expression profile of pro- and anti-inflammatory genes and proteins as well as the number of activated microglia (express major histocompatibility complex II; MHC II) and the integrity and density of ascending catecholaminergic neural systems originating from the locus coeruleus (LC) and substantia nigra pars compacta (SNpc) in rats. LPS infusion increased gene expression and/or protein levels for both pro- and anti-inflammatory biomarkers. Although LPS infusion stimulated a robust increase in IL-1ß gene and protein expression, this increase was blunted with age. LPS infusion also increased the density of activated microglia cells throughout the midbrain and brainstem. Corresponding to the development of a pro-inflammatory environment, LC and SNpc neurons immunopositive for tyrosine-hydroxylase (the rate-limiting synthetic enzyme for dopamine and norepinephrine) decreased in number, along with a decrease in tyrosine-hydroxylase gene expression in the midbrain and/or brainstem region. Our data support the concept that continuous exposure to a pro-inflammatory environment drives exaggerated changes in the production and release of inflammatory mediators that interact with age to impair functional capacity of the SNpc and LC.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aging; Alzheimer's disease; Cytokines; Locus coeruleus; Microglia; Neuroinflammation; Parkinson's disease; Rat; Substantia nigra

Mesh:

Substances:

Year:  2013        PMID: 24315728      PMCID: PMC3946275          DOI: 10.1016/j.neurobiolaging.2013.11.006

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  67 in total

1.  Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia.

Authors:  W G Kim; R P Mohney; B Wilson; G H Jeohn; B Liu; J S Hong
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

2.  Selective changes in the contents of noradrenaline, dopamine and serotonin in rat brain areas during aging.

Authors:  J M Míguez; M Aldegunde; L Paz-Valiñas; J Recio; E Sánchez-Barceló
Journal:  J Neural Transm (Vienna)       Date:  1999       Impact factor: 3.575

3.  Risk and incidence of dementia in a cohort of older subjects with Parkinson's disease in the United Kingdom.

Authors:  Peter Hobson; Jolyon Meara
Journal:  Mov Disord       Date:  2004-09       Impact factor: 10.338

4.  Positive and negative regulation of EAAT2 by NF-kappaB: a role for N-myc in TNFalpha-controlled repression.

Authors:  Raquel Sitcheran; Pankaj Gupta; Paul B Fisher; Albert S Baldwin
Journal:  EMBO J       Date:  2005-01-20       Impact factor: 11.598

5.  Compensatory changes in the noradrenergic nervous system in the locus ceruleus and hippocampus of postmortem subjects with Alzheimer's disease and dementia with Lewy bodies.

Authors:  Patricia Szot; Sylvia S White; J Lynne Greenup; James B Leverenz; Elaine R Peskind; Murray A Raskind
Journal:  J Neurosci       Date:  2006-01-11       Impact factor: 6.167

6.  Morphometry of the human substantia nigra in ageing and Parkinson's disease.

Authors:  Gay Rudow; Richard O'Brien; Alena V Savonenko; Susan M Resnick; Alan B Zonderman; Olga Pletnikova; Laura Marsh; Ted M Dawson; Barbara J Crain; Mark J West; Juan C Troncoso
Journal:  Acta Neuropathol       Date:  2008-02-23       Impact factor: 17.088

7.  Riluzole partially rescues age-associated, but not LPS-induced, loss of glutamate transporters and spatial memory.

Authors:  Holly M Brothers; Isabelle Bardou; Sarah C Hopp; Roxanne M Kaercher; Angela W Corona; Ashley M Fenn; Jonathan P Godbout; Gary L Wenk
Journal:  J Neuroimmune Pharmacol       Date:  2013-05-25       Impact factor: 4.147

8.  Pro-inflammatory cytokines modulate iron regulatory protein 1 expression and iron transportation through reactive oxygen/nitrogen species production in ventral mesencephalic neurons.

Authors:  Jia Wang; Ning Song; Hong Jiang; Jun Wang; Junxia Xie
Journal:  Biochim Biophys Acta       Date:  2013-01-31

9.  The inflammatory cytokine, interleukin-1 beta, mediates loss of astroglial glutamate transport and drives excitotoxic motor neuron injury in the spinal cord during acute viral encephalomyelitis.

Authors:  Natalie A Prow; David N Irani
Journal:  J Neurochem       Date:  2008-01-14       Impact factor: 5.372

10.  Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.

Authors:  W S Griffin; L C Stanley; C Ling; L White; V MacLeod; L J Perrot; C L White; C Araoz
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

View more
  26 in total

Review 1.  Mild cold-stress depresses immune responses: Implications for cancer models involving laboratory mice.

Authors:  Michelle N Messmer; Kathleen M Kokolus; Jason W-L Eng; Scott I Abrams; Elizabeth A Repasky
Journal:  Bioessays       Date:  2014-07-25       Impact factor: 4.345

2.  Differential neuroprotective and anti-inflammatory effects of L-type voltage dependent calcium channel and ryanodine receptor antagonists in the substantia nigra and locus coeruleus.

Authors:  Sarah C Hopp; Sarah E Royer; Heather M D'Angelo; Roxanne M Kaercher; David A Fisher; Gary L Wenk
Journal:  J Neuroimmune Pharmacol       Date:  2014-10-16       Impact factor: 4.147

Review 3.  Helicobacter pylori and neurological diseases: Married by the laws of inflammation.

Authors:  Lourdes Alvarez-Arellano; Carmen Maldonado-Bernal
Journal:  World J Gastrointest Pathophysiol       Date:  2014-11-15

Review 4.  Ethanol and Cytokines in the Central Nervous System.

Authors:  Marisa Roberto; Reesha R Patel; Michal Bajo
Journal:  Handb Exp Pharmacol       Date:  2018

5.  Dysregulation of TLR5 and TAM Ligands in the Alzheimer's Brain as Contributors to Disease Progression.

Authors:  Marisol Herrera-Rivero; Francesco Santarelli; Frederic Brosseron; Markus P Kummer; Michael T Heneka
Journal:  Mol Neurobiol       Date:  2019-03-09       Impact factor: 5.590

6.  Neuroprotective Effects of Intranasal IGF-1 against Neonatal Lipopolysaccharide-Induced Neurobehavioral Deficits and Neuronal Inflammation in the Substantia Nigra and Locus Coeruleus of Juvenile Rats.

Authors:  Lu-Tai Tien; Yih-Jing Lee; Yi Pang; Silu Lu; Jonathan W Lee; Chih-Hsueh Tseng; Abhay J Bhatt; Renate D Savich; Lir-Wan Fan
Journal:  Dev Neurosci       Date:  2017-08-05       Impact factor: 2.984

Review 7.  From adolescence to late aging: A comprehensive review of social behavior, alcohol, and neuroinflammation across the lifespan.

Authors:  Amy E Perkins; Elena I Varlinskaya; Terrence Deak
Journal:  Int Rev Neurobiol       Date:  2019-08-24       Impact factor: 3.230

8.  Late aging-associated increases in L-DOPA-induced dyskinesia are accompanied by heightened neuroinflammation in the hemi-parkinsonian rat.

Authors:  Kathryn Lanza; Amy E Perkins; Terrence Deak; Christopher Bishop
Journal:  Neurobiol Aging       Date:  2019-05-31       Impact factor: 4.673

Review 9.  Dysfunctional Sensory Modalities, Locus Coeruleus, and Basal Forebrain: Early Determinants that Promote Neuropathogenesis of Cognitive and Memory Decline and Alzheimer's Disease.

Authors:  Mak Adam Daulatzai
Journal:  Neurotox Res       Date:  2016-06-23       Impact factor: 3.911

10.  MRI-assessed locus coeruleus integrity is heritable and associated with multiple cognitive domains, mild cognitive impairment, and daytime dysfunction.

Authors:  Jeremy A Elman; Olivia K Puckett; Asad Beck; Christine Fennema-Notestine; Latonya K Cross; Anders M Dale; Graham M L Eglit; Lisa T Eyler; Nathan A Gillespie; Eric L Granholm; Daniel E Gustavson; Donald J Hagler; Sean N Hatton; Richard Hauger; Amy J Jak; Mark W Logue; Linda K McEvoy; Ruth E McKenzie; Michael C Neale; Matthew S Panizzon; Chandra A Reynolds; Mark Sanderson-Cimino; Rosemary Toomey; Xin M Tu; Nathan Whitsel; McKenna E Williams; Hong Xian; Michael J Lyons; Carol E Franz; William S Kremen
Journal:  Alzheimers Dement       Date:  2021-02-13       Impact factor: 21.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.